CALGARY, Dec. 19 /CNW/ - The Board of Directors of Epicore BioNetworks Inc. is pleased to announce that the Company has signed an agreement with RootX Inc. of Salem Oregon wherein RootX Inc. will become the exclusive distributor for Epicore's municipal grease digestion products in North America and certain other territories. RootX Inc. has over 30 years in the pipeline maintenance business and currently manufactures and sells the pipeline root control product RootX(R) for municipal sewer agencies and Drain Cleaning Contractors. RootX Inc. markets and sells the RootX(R) root control product in the United States and Canada with a direct sales force and plans to include the Epicore municipal grease digestion products in this same program.
Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity. Epicore's technology includes biological and biochemical products to digest grease and other organic matter that can block water discharge lines.
The alliance of Epicore grease digestion technology and RootX Inc. marketing excellence is expected to yield impressive results for both organizations. The alliance lessens Epicore's heavy reliance on aquaculture business and provides a base for the development of an environmental division for Epicore.
Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)
This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.